Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Usefulness of Tricuspid Annular Diameter to Predict Late Right Sided Heart Failure in Patients With Left Ventricular Assist Device.

Nakanishi K, Homma S, Han J, Takayama H, Colombo PC, Yuzefpolskaya M, Garan AR, Farr MA, Kurlansky P, Di Tullio MR, Naka Y, Takeda K.

Am J Cardiol. 2018 Mar 28. pii: S0002-9149(18)30378-3. doi: 10.1016/j.amjcard.2018.03.010. [Epub ahead of print]

PMID:
29673504
2.

Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.

Truby LK, Garan AR, Givens RC, Takeda K, Takayama H, Trinh PN, Yuzefpolskaya M, Farr MA, Naka Y, Colombo PC, Topkara VK.

Circ Heart Fail. 2018 Apr;11(4):e004586. doi: 10.1161/CIRCHEARTFAILURE.117.004586.

PMID:
29666073
3.

Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.

Sridharan L, Wayda B, Truby LK, Latif F, Restaino S, Takeda K, Takayama H, Naka Y, Colombo PC, Maurer M, Farr MA, Topkara VK.

Circ Heart Fail. 2018 Mar;11(3):e004665. doi: 10.1161/CIRCHEARTFAILURE.117.004665.

PMID:
29664407
4.

Socioeconomic Disparities in Adherence and Outcomes After Heart Transplant: A UNOS (United Network for Organ Sharing) Registry Analysis.

Wayda B, Clemons A, Givens RC, Takeda K, Takayama H, Latif F, Restaino S, Naka Y, Farr MA, Colombo PC, Topkara VK.

Circ Heart Fail. 2018 Mar;11(3):e004173. doi: 10.1161/CIRCHEARTFAILURE.117.004173.

PMID:
29664403
5.

Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis.

Jennings DL, Lange N, Shullo M, Latif F, Restaino S, Topkara VK, Takeda K, Takayama H, Naka Y, Farr M, Colombo P, Baker WL.

Int J Cardiol. 2018 Mar 24. pii: S0167-5273(18)31103-3. doi: 10.1016/j.ijcard.2018.03.111. [Epub ahead of print]

PMID:
29605470
6.

Implementing online consultations in primary care: a mixed-method evaluation extending normalisation process theory through service co-production.

Farr M, Banks J, Edwards HB, Northstone K, Bernard E, Salisbury C, Horwood J.

BMJ Open. 2018 Mar 19;8(3):e019966. doi: 10.1136/bmjopen-2017-019966.

7.

A continuous-flow external ventricular assist device for cardiogenic shock: Evolution over 10 years.

Ando M, Garan AR, Takayama H, Topkara VK, Han J, Kurlansky P, Yuzefpolskaya M, Farr MA, Colombo PC, Naka Y, Takeda K.

J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30353-2. doi: 10.1016/j.jtcvs.2017.12.148. [Epub ahead of print]

PMID:
29510941
8.

Comparative Assessment of Anti-HLA Antibodies Using Two Commercially Available Luminex-Based Assays.

Clerkin KJ, See SB, Farr MA, Restaino SW, Serban G, Latif F, Li L, Colombo PC, Vlad G, Ray B, Vasilescu ER, Zorn E.

Transplant Direct. 2017 Oct 2;3(11):e218. doi: 10.1097/TXD.0000000000000734. eCollection 2017 Nov.

9.

Use of a primary care online consultation system, by whom, when and why: evaluation of a pilot observational study in 36 general practices in South West England.

Edwards HB, Marques E, Hollingworth W, Horwood J, Farr M, Bernard E, Salisbury C, Northstone K.

BMJ Open. 2017 Nov 22;7(11):e016901. doi: 10.1136/bmjopen-2017-016901.

10.

Use of an electronic consultation system in primary care: a qualitative interview study.

Banks J, Farr M, Salisbury C, Bernard E, Northstone K, Edwards H, Horwood J.

Br J Gen Pract. 2018 Jan;68(666):e1-e8. doi: 10.3399/bjgp17X693509. Epub 2017 Nov 6.

11.

Molecular autopsy of sudden unexplained deaths reveals genetic predispositions for cardiac diseases among young forensic cases.

Hellenthal N, Gaertner-Rommel A, Klauke B, Paluszkiewicz L, Stuhr M, Kerner T, Farr M, Püschel K, Milting H.

Europace. 2017 Nov 1;19(11):1881-1890. doi: 10.1093/europace/euw247.

PMID:
29016939
12.

Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients.

Salna M, Takayama H, Garan AR, Kurlansky P, Farr MA, Colombo PC, Imahiyerobo T, Morrissey N, Naka Y, Takeda K.

J Vasc Surg. 2018 Feb;67(2):542-548. doi: 10.1016/j.jvs.2017.05.127. Epub 2017 Aug 16.

PMID:
28822659
13.

Can Staff Be Supported to Deliver Compassionate Care Through Implementing Schwartz Rounds in Community and Mental Health Services?

Farr M, Barker R.

Qual Health Res. 2017 Sep;27(11):1652-1663. doi: 10.1177/1049732317702101. Epub 2017 Apr 13.

PMID:
28799475
14.

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case.

Fox H, Farr M, Horstkotte D, Flottmann C.

Case Rep Cardiol. 2017;2017:9231959. doi: 10.1155/2017/9231959. Epub 2017 Jul 12.

15.

Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.

Truby LK, Takeda K, Farr M, Beck J, Yuzefpolskaya M, Colombo PC, Topkara VK, Mancini D, Naka Y, Takayama H.

ASAIO J. 2018 Jan/Feb;64(1):43-51. doi: 10.1097/MAT.0000000000000623.

PMID:
28777136
16.

Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration.

Takeda K, Garan AR, Ando M, Han J, Topkara VK, Kurlansky P, Yuzefpolskaya M, Farr MA, Colombo PC, Naka Y, Takayama H.

Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1055-1061. doi: 10.1093/ejcts/ezx189.

PMID:
28651347
17.

Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation.

Wright M, Takeda K, Mauro C, Jennings D, Kurlansky P, Han J, Truby L, Stein S, Topkara V, Garan AR, Yuzefpolskaya M, Colombo P, Naka Y, Farr M, Takayama H.

J Heart Lung Transplant. 2017 Nov;36(11):1226-1233. doi: 10.1016/j.healun.2017.05.025. Epub 2017 May 20.

PMID:
28583372
18.

Balloon Eustachian tuboplasty treatment of longstanding Eustachian tube dysfunction.

Singh T, Taneja V, Kulendra K, Farr M, Robinson J, Rejali D.

J Laryngol Otol. 2017 Jul;131(7):614-619. doi: 10.1017/S0022215117000974. Epub 2017 May 15.

PMID:
28502258
19.

Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.

See SB, Clerkin KJ, Kennel PJ, Zhang F, Weber MP, Rogers KJ, Chatterjee D, Vasilescu ER, Vlad G, Naka Y, Restaino SW, Farr MA, Topkara VK, Colombo PC, Mancini DM, Schulze PC, Levin B, Zorn E.

J Heart Lung Transplant. 2017 Aug;36(8):862-870. doi: 10.1016/j.healun.2017.03.018. Epub 2017 Mar 24.

PMID:
28431981
20.

The new United States heart allocation policy: Progress through collaborative revision.

Davies RR, Farr M, Silvestry S, Callahan LR, Edwards L, Meyer DM, Uccellini K, Chan KM, Rogers JG.

J Heart Lung Transplant. 2017 Jun;36(6):595-596. doi: 10.1016/j.healun.2017.03.010. Epub 2017 Mar 21. No abstract available.

PMID:
28396089
21.

Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

Bahiru E, de Cates AN, Farr MR, Jarvis MC, Palla M, Rees K, Ebrahim S, Huffman MD.

Cochrane Database Syst Rev. 2017 Mar 6;3:CD009868. doi: 10.1002/14651858.CD009868.pub3. Review.

PMID:
28263370
22.

Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.

Takeda K, Li B, Garan AR, Topkara VK, Han J, Colombo PC, Farr MA, Naka Y, Takayama H.

J Heart Lung Transplant. 2017 Jun;36(6):650-656. doi: 10.1016/j.healun.2016.12.006. Epub 2016 Dec 23.

PMID:
28087104
23.

Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.

Clerkin KJ, Farr MA, Restaino SW, Zorn E, Latif F, Vasilescu ER, Marboe CC, Colombo PC, Mancini DM.

J Heart Lung Transplant. 2017 May;36(5):540-545. doi: 10.1016/j.healun.2016.10.016. Epub 2016 Nov 17.

PMID:
27916323
24.

Three year experience with the cochlear BAHA attract implant: a systematic review of the literature.

Dimitriadis PA, Farr MR, Allam A, Ray J.

BMC Ear Nose Throat Disord. 2016 Oct 1;16:12. eCollection 2016.

25.

Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.

Fatima A, Ivanyuk D, Herms S, Heilmann-Heimbach S, O'Shea O, Chapman C, Izsvák Z, Farr M, Hescheler J, Šarić T.

Stem Cell Res. 2016 Mar;16(2):304-7. doi: 10.1016/j.scr.2015.12.039. Epub 2016 Jan 6.

26.

The Role of Sociocultural Influences on Symptoms of Muscle Dysmorphia and Eating Disorders in Men, and the Mediating Effects of Perfectionism.

Dryer R, Farr M, Hiramatsu I, Quinton S.

Behav Med. 2016 Jul-Sep;42(3):174-82. doi: 10.1080/08964289.2015.1122570.

PMID:
27337621
27.

Dobutamine stress echocardiography is inadequate to detect early cardiac allograft vasculopathy.

Clerkin KJ, Farr MA, Restaino SW, Ali ZA, Mancini DM.

J Heart Lung Transplant. 2016 Aug;35(8):1040-1. doi: 10.1016/j.healun.2016.05.012. Epub 2016 May 21. No abstract available.

28.

Tubular Carcinoma of the Breast: A Single Institution's Experience of a Favorable Prognosis.

Boyan W, Shea B, Farr M, Kohli M, Ginalis E.

Am Surg. 2016 Jun;82(6):505-9.

PMID:
27305881
29.

[Homozygous hypercholesterolemia - new therapeutic options in cases with complete lack of LDL- receptor].

Mellwig KP, Farr M, Diekmann J, Horstkotte D, van Buuren F.

Dtsch Med Wochenschr. 2016 Jun;141(12):878-81. doi: 10.1055/s-0041-109013. Epub 2016 Jun 15. German.

PMID:
27305304
30.

Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy.

Varr BC, Restaino SW, Farr M, Scully B, Colombo PC, Naka Y, Mancini DM.

J Heart Lung Transplant. 2016 Sep;35(9):1116-23. doi: 10.1016/j.healun.2016.04.016. Epub 2016 May 11.

PMID:
27289301
31.

Who's Ordering the CT Anyway? A Study of the Frequency of CT Scan Use in Acute Appendicitis.

Boyan W, Dinallo A, Farr M, Protyniak B, Goldfarb M.

Am Surg. 2016 Apr;82(4):E87-8. No abstract available.

PMID:
27097614
32.

Development of risk models for the prediction of new or worsening acute kidney injury on or during hospital admission: a cohort and nested study.

Bedford M, Stevens P, Coulton S, Billings J, Farr M, Wheeler T, Kalli M, Mottishaw T, Farmer C.

Southampton (UK): NIHR Journals Library; 2016 Feb.

33.

Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.

Dixit N, Castano A, Farr MJ, Traub R, Lentzsch S, Brown RS Jr, Maurer MS, Brannagan TH 3rd.

J Clin Neuromuscul Dis. 2016 Mar;17(3):142-5. doi: 10.1097/CND.0000000000000110.

PMID:
26905915
34.

Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement.

Lee M, Akashi H, Kato TS, Takayama H, Wu C, Xu K, Collado E, Weber MP, Kennel PJ, Brunjes DL, Ji R, Naka Y, George I, Mancini D, Farr M, Schulze PC.

J Heart Lung Transplant. 2016 Sep;35(9):1085-91. doi: 10.1016/j.healun.2015.12.027. Epub 2016 Jan 6.

35.

A Month for Gallbladder Cancer: A Case Report of Four Gallbladder Cancers Over a 30-Day Period at a Community Hospital.

Boyan WP Jr, Klepner S, Farr M, Kopelan A, Paragi P, Clarke K.

World J Oncol. 2015 Dec;6(6):495-498. doi: 10.14740/wjon951w. Epub 2015 Dec 31.

36.

Outcomes of Adult Patients With Congenital Heart Disease After Heart Transplantation: Impact of Disease Type, Previous Thoracic Surgeries, and Bystander Organ Dysfunction.

Lewis M, Ginns J, Schulze C, Lippel M, Chai P, Bacha E, Mancini D, Rosenbaum M, Farr M.

J Card Fail. 2016 Jul;22(7):578-82. doi: 10.1016/j.cardfail.2015.09.002. Epub 2015 Nov 11.

PMID:
26432646
37.

Developing a one-stop tinnitus service: outcomes of a joined up management strategy: a retrospective observational cohort study.

Farr MR, Moraleda Deleito J, Xu Y, Ray J.

J Eval Clin Pract. 2016 Feb;22(1):93-97. doi: 10.1111/jep.12442. Epub 2015 Aug 28.

PMID:
26314274
38.

Left and Right Ventricular Functional Dynamics Determined by Echocardiograms Before and After Lung Transplantation.

Kato TS, Armstrong HF, Schulze PC, Lippel M, Amano A, Farr M, Bacchetta M, Bartels MN, Di Tullio MR, Homma S, Mancini D.

Am J Cardiol. 2015 Aug 15;116(4):652-9. doi: 10.1016/j.amjcard.2015.05.027. Epub 2015 May 21.

39.

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.

Chung ES, Miller L, Patel AN, Anderson RD, Mendelsohn FO, Traverse J, Silver KH, Shin J, Ewald G, Farr MJ, Anwaruddin S, Plat F, Fisher SJ, AuWerter AT, Pastore JM, Aras R, Penn MS.

Eur Heart J. 2015 Sep 1;36(33):2228-38. doi: 10.1093/eurheartj/ehv254. Epub 2015 Jun 7.

40.

Understanding staff perspectives of quality in practice in healthcare.

Farr M, Cressey P.

BMC Health Serv Res. 2015 Apr 23;15:123. doi: 10.1186/s12913-015-0788-1.

41.

Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.

Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, Dove L, Jorde UP, Takayama H, Emond J, Naka Y, Mancini D, Lefkowitch JH, Schulze PC.

J Heart Lung Transplant. 2015 Jul;34(7):873-82. doi: 10.1016/j.healun.2014.12.009. Epub 2014 Dec 23.

42.
43.

Similar survival in patients following heart transplantation receiving induction therapy using daclizumab vs. basiliximab.

Martin ST, Kato TS, Farr M, McKeen JT, Cheema F, Ji M, Ross A, Yerebakan H, Naka Y, Takayama H, Restaino S, Mancini D, Schulze PC.

Circ J. 2015;79(2):368-374. doi: 10.1253/circj.CJ-14-0718. Epub 2014 Dec 12.

44.

Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience.

Clerkin KJ, Thomas SS, Haythe J, Schulze PC, Farr M, Takayama H, Jorde UP, Restaino SW, Naka Y, Mancini DM.

J Heart Lung Transplant. 2015 Feb;34(2):161-6. doi: 10.1016/j.healun.2014.09.033. Epub 2014 Sep 28.

45.

High grade angiosarcoma fifteen years after breast conservation therapy with radiation therapy: A case report.

Boyan W Jr, Farr M, Georges R.

Int J Surg Case Rep. 2014;5(12):1176-7. doi: 10.1016/j.ijscr.2014.11.042. Epub 2014 Nov 18.

46.

The role the Great Barrier Reef plays in resident wellbeing and implications for its management.

Larson S, Stoeckl N, Farr M, Esparon M.

Ambio. 2015 Apr;44(3):166-77. doi: 10.1007/s13280-014-0554-3. Epub 2014 Sep 20.

47.

Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.

Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y, Templeton DL, George I, Farr MA, Mancini DM, Schulze PC.

J Heart Lung Transplant. 2014 Dec;33(12):1215-22. doi: 10.1016/j.healun.2014.06.007. Epub 2014 Jun 23.

48.

Fixed-dose combination therapy for the prevention of cardiovascular disease.

de Cates AN, Farr MR, Wright N, Jarvis MC, Rees K, Ebrahim S, Huffman MD.

Cochrane Database Syst Rev. 2014 Apr 16;(4):CD009868. doi: 10.1002/14651858.CD009868.pub2. Review.

49.

Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery.

Kato TS, Jiang J, Schulze PC, Jorde U, Uriel N, Kitada S, Takayama H, Naka Y, Mancini D, Gillam L, Homma S, Farr M.

JACC Heart Fail. 2013 Jun;1(3):216-22. doi: 10.1016/j.jchf.2013.02.005. Epub 2013 Jun 3.

50.

Left ventricular longitudinal strain by speckle-tracking echocardiography is associated with treatment-requiring cardiac allograft rejection.

Sera F, Kato TS, Farr M, Russo C, Jin Z, Marboe CC, Di Tullio MR, Mancini D, Homma S.

J Card Fail. 2014 May;20(5):359-64. doi: 10.1016/j.cardfail.2014.02.006. Epub 2014 Feb 21.

PMID:
24561182

Supplemental Content

Support Center